A user contacted the manufacturer regarding the sound abatement foam correction/removal for their cpap device.The user reported burning/smoke/electrical odor; noise; nose bleeds, congestion, coughing phlegm; mouth sores/bleeding; nasal/throat irritation.There was no allegation of serious or permanent harm or injury.This issue was reported to the fda per 21 cfr 806.The device will be corrected per res 88058.
|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer previously reported an allegation of an issue related to a cpap device's sound abatement foam.The patient alleged burning/smoke/electrical odor; noise; nose bleeds, congestion, coughing phlegm; mouth sores/bleeding; nasal/throat irritation.There was no allegation of serious or permanent harm or injury.The device was returned to the manufacturer's product investigation laboratory for investigation.During investigation, evidence of sound abatement foam degradation/breakdown was not observed in the base unit.Observes dust/dirt and fibrous contamination, inconsistent with sound abatement foam degradation, throughout the device enclosure and airpath, suggesting that it originated from an external source.Observes brown/yellow contamination throughout the device enclosure, suggesting a source external to the device.Observes evidence of water ingress in the blower box and blower, suggesting the use of non-distilled water in the humidifier water chamber.Slight black contamination at the blower seal of the blower box is consistent with the keratin contamination observed.The device's downloaded event log was reviewed by the manufacturer and found no errors.The manufacturer concludes unable to address the symptoms described.Pil can confirm the presence of contamination in the airpath.Can confirm the device powers on and provides airflow.Can confirm evidence of water ingress in the blower box.
|